MoneyWorks4Me

Indoco Remedies informs about revised schedule of con-call meeting

08 Nov 2022 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed about revised schedule of the Con-Call meeting planned for Friday, November 11, 2022. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..